Top Industry Leaders in the Bipolar Disorders Treatment Market
Latest Bipolar Disorders Treatment Companies Update:
Alkermes Received US FDA approval for LYBALVITM (olanzapine and samidorphan), the first combination medication specifically approved for the treatment of bipolar I disorder.
Johnson & Johnson Acquired Spindrift Pharmaceuticals, a company developing novel gene therapy treatments for bipolar disorder and other neurological conditions.
Evidation Health Launched a digital health platform for bipolar disorder management, providing personalized insights and support to patients and their caregivers.
Mindstrong Health Received funding from GV (formerly Google Ventures) to expand its virtual therapy platform for mental health conditions, including bipolar disorder.
Sage Therapeutics Presented positive Phase 3 trial results for zuranolone, a novel neuroactive steroid medication, in the treatment of bipolar depression.
List of Bipolar Disorders Treatment Key companies in the market
- Allergan
- AstraZeneca
- Eli Lilly and Company
- GlaxoSmithKline
- Abbott
- Bristol-Myers Squibb
- Johnson & Johnson
- Pfizer Inc.
- Cephalon Inc.
- Otsuka America Pharmaceutical Inc.
- Gedeon Richter plc